摘要
目的:研究microRNA-192基因表达降低与恶性黑素瘤A375细胞增殖及凋亡的关系。方法:除空白对照组外,运用脂质体介导法将空载体和为microRNA-192设计的small interfering RNA(si RNA)转染到恶性黑素瘤A375细胞中,并利用实时定量PCR检测microRNA-192的表达。通过形态学观察、细胞计数法、3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)比色法以及流式细胞免疫学等方法,分析空白对照组、空载体对照组(lipofectamine2000)和实验组恶性黑素瘤A375细胞的增殖和早期凋亡情况。结果:空白对照组和空载体对照组之间相比较,细胞增殖和凋亡情况几乎一致,差异无统计学意义。与空载体对照组相比,实验组存活的恶性黑素瘤A375细胞的活性和数量明显降低,此现象并随着si RNA浓度的提高而愈发明显。另外,实验组恶性黑素瘤A375细胞细胞凋亡指数较空载体对照组明显升高。结论:通过下调恶性黑素瘤细胞中microRNA-192基因表达可能会有效地抑制恶性黑素瘤的生长并促使其细胞凋亡。
Objective: We assessed whether microRNA-192 deficiency influences the proliferation and apoptosis in A375 melanoma cell line. Methods: A375 melanoma cells were transfected with lipofeetamine alone or small interfering RNA(MicroRNA-1192 siR NA)-loaded lipofectamine. A group of untreated cells served as an additional normal control. The expression of mieroRNA-192 was analyzed with real-time PCR Cell proliferation and early apoptosis were assessed with inverted microscope, MTI' assay, and flow cytometry. Result: There were no significant differences in proliferation and apoptosis between normal controls and cells-treated with lipofectamine alone. In comparison with ]ipofectamine alone, siRNA treatment induced significant reduction in cell activity and the number of the A375 melanoma cells in a dose-dependent manner. Additionally, transfection with MicroRNA-1192 siRNA dramatical- ly increased apoptosis index. Conclusion: Downregulation of microRNA-192 can effectively inhibit the proliferation and accelerate the apoptosis in A375 melanoma cell line.
出处
《临床皮肤科杂志》
CAS
CSCD
北大核心
2017年第1期4-7,共4页
Journal of Clinical Dermatology